chr6-159197499-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_032532.3(FNDC1):c.178G>A(p.Asp60Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032532.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FNDC1 | NM_032532.3 | c.178G>A | p.Asp60Asn | missense_variant | 2/23 | ENST00000297267.14 | |
FNDC1 | XM_011536190.3 | c.178G>A | p.Asp60Asn | missense_variant | 2/22 | ||
FNDC1 | XM_011536191.3 | c.110-17446G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FNDC1 | ENST00000297267.14 | c.178G>A | p.Asp60Asn | missense_variant | 2/23 | 1 | NM_032532.3 | P1 | |
FNDC1 | ENST00000329629.8 | c.55G>A | p.Asp19Asn | missense_variant | 1/21 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 249042Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135088
GnomAD4 exome AF: 0.0000493 AC: 72AN: 1461626Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 727094
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.178G>A (p.D60N) alteration is located in exon 2 (coding exon 2) of the FNDC1 gene. This alteration results from a G to A substitution at nucleotide position 178, causing the aspartic acid (D) at amino acid position 60 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at